Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation

Cancer Cell

Volumn 22, Issue 5, 2012, Pages 645-655

  Mishra, Anjali ^a,b,c   Liu, Shujun ^b   Sams, Gregory H ^a,b   Curphey, Douglas P ^a,b   Santhanam, Ramasamy ^a   Rush, Laura J ^a   Schaefer, Deanna ^a   Falkenberg, Lauren G ^a,b   Sullivan, Laura ^a,b   Jaroncyk, Laura ^a,b   Yang, Xiaojuan ^a,c   Fisk, Harold ^a   Wu, Lai Chu ^a   Hickey, Christopher ^c   Chandler, Jason C ^b   Wu, Yue Zhong ^b   Heerema, Nyla A ^a   Chan, Kenneth K ^a,c   Perrotti, Danilo ^a,c   Zhang, Jianying ^a,c   Porcu, Pierluigi ^b,c   Racke, Frederick K ^a   Garzon, Ramiro ^b,c   Lee, Robert J ^a,c   Marcucci, Guido ^a,b,c   Caligiuri, Michael A ^a,b,c   more..

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA KINASE INHIBITOR; DNA METHYLTRANSFERASE 3B; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; MICRORNA 29B; MYC PROTEIN;

ADOPTIVE TRANSFER; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA HYPEREMETHYLATION; DNA METHYLATION; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WILD TYPE;

EID: 84869006006     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.09.009     Document Type: Article

References (47)

1. Aboud M., Golde D.W., Bersch N., Rosenblatt J.D., Chen I.S. A colony assay for in vitro transformation by human T cell leukemia viruses type I and type II. Blood 1987, 70:432-436.
2. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA 1995, 92:5258-5265.
3. Asadullah K., Haeussler-Quade A., Gellrich S., Hanneken S., Hansen-Hagge T.E., Döcke W.D., Volk H.D., Sterry W. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression. Exp. Dermatol. 2000, 9:248-251.
4. Azimi N., Brown K., Bamford R.N., Tagaya Y., Siebenlist U., Waldmann T.A. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc. Natl. Acad. Sci. USA 1998, 95:2452-2457.
5. Azimi N., Jacobson S., Leist T., Waldmann T.A. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J. Immunol. 1999, 163:4064-4072.
6. Baldassarre G., Fedele M., Battista S., Vecchione A., Klein-Szanto A.J., Santoro M., Waldmann T.A., Azimi N., Croce C.M., Fusco A. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 2001, 98:7970-7975.
7. Bamford R.N., Grant A.J., Burton J.D., Peters C., Kurys G., Goldman C.K., Brennan J., Roessler E., Waldmann T.A. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994, 91:4940-4944.
8. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998, 17:3052-3065.
9. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
10. Carroll H.P., Paunovic V., Gadina M. Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology (Oxford) 2008, 47:1269-1277.
11. Chan K.K., Liu Z., Xie Z., Chiu M., Wang H., Chen P., Dunkerson S., Chiu M., Liu S., Triantafillou G., et al. A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application. AAPS J. 2010, 12:556-568.
12. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
13. D'Auria L., Bonifati C., Cordiali-Fei P., Leone G., Picardo M., Pietravalle M., Giacalone B., Ameglio F. Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity. Arch. Dermatol. Res. 1999, 291:354-356.
14. den Hollander J., Rimpi S., Doherty J.R., Rudelius M., Buck A., Hoellein A., Kremer M., Graf N., Scheerer M., Hall M.A., et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 2010, 116:1498-1505.
15. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 2004, 4:11-22.
16. Dubois S., Mariner J., Waldmann T.A., Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002, 17:537-547.
17. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
18. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Oshiro M., Kothapalli R., Li Y., Wang J.-M., Yang-Yen H.-F., Karras J., et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 2001, 107:351-362.
19. Estécio M.R., Gharibyan V., Shen L., Ibrahim A.E., Doshi K., He R., Jelinek J., Yang A.S., Yan P.S., Huang T.H., et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE 2007, 2:e399.
20. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br. J. Cancer 2006, 94:179-183.
21. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8:286-298.
22. Fehniger T.A., Suzuki K., Ponnappan A., VanDeusen J.B., Cooper M.A., Florea S.M., Freud A.G., Robinson M.L., Durbin J., Caligiuri M.A. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 2001, 193:219-231.
23. Ganem N.J., Godinho S.A., Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282.
24. Garzon R., Heaphy C.E., Havelange V., Fabbri M., Volinia S., Tsao T., Zanesi N., Kornblau S.M., Marcucci G., Calin G.A., et al. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009, 114:5331-5341.
25. Garzon R., Liu S., Fabbri M., Liu Z., Heaphy C.E., Callegari E., Schwind S., Pang J., Yu J., Muthusamy N., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418.
26. Giet R., Petretti C., Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?. Trends Cell Biol. 2005, 15:241-250.
27. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
28. Hodge D.L., Yang J., Buschman M.D., Schaughency P.M., Dang H., Bere W., Yang Y., Savan R., Subleski J.J., Yin X.M., et al. Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res. 2009, 69:3986-3994.
29. Hudson J.D., Shoaibi M.A., Maestro R., Carnero A., Hannon G.J., Beach D.H. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 1999, 190:1375-1382.
30. Johnston J.A., Bacon C.M., Finbloom D.S., Rees R.C., Kaplan D., Shibuya K., Ortaldo J.R., Gupta S., Chen Y.Q., Giri J.D., et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 1995, 92:8705-8709.
31. Kanda A., Kawai H., Suto S., Kitajima S., Sato S., Takata T., Tatsuka M. Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation. Oncogene 2005, 24:7266-7272.
32. Koskela H.L., Eldfors S., Ellonen P., van Adrichem A.J., Kuusanmäki H., Andersson E.I., Lagström S., Clemente M.J., Olson T., Jalkanen S.E., et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N. Engl. J. Med. 2012, 366:1905-1913.
33. Liu S., Wu L.C., Pang J., Santhanam R., Schwind S., Wu Y.Z., Hickey C.J., Yu J., Becker H., Maharry K., et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010, 17:333-347.
34. Morris J.C., Janik J.E., White J.D., Fleisher T.A., Brown M., Tsudo M., Goldman C.K., Bryant B., Petrus M., Top L., et al. Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc. Natl. Acad. Sci. USA 2006, 103:401-406.
35. Ogilvy S., Elefanty A.G., Visvader J., Bath M.L., Harris A.W., Adams J.M. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood 1998, 91:419-430.
36. Ogino S., Kawasaki T., Nosho K., Ohnishi M., Suemoto Y., Kirkner G.J., Fuchs C.S. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int. J. Cancer 2008, 122:2767-2773.
37. Park I.K., Giovenzana C., Hughes T.L., Yu J., Trotta R., Caligiuri M.A. The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood 2009, 113:2470-2477.
38. Renauld J.C., van der Lugt N., Vink A., van Roon M., Godfraind C., Warnier G., Merz H., Feller A., Berns A., Van Snick J. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 1994, 9:1327-1332.
39. Sokol L., Loughran T.P. Large granular lymphocyte leukemia. Oncologist 2006, 11:263-273.
40. Trentin L., Zambello R., Facco M., Sancetta R., Agostini C., Semenzato G. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymphoma 1997, 27:35-42.
41. Utecht K.N., Kolesar J. Bortezomib: a novel chemotherapeutic agent for hematologic malignancies. Am. J. Health Syst. Pharm. 2008, 65:1221-1231.
42. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 1999, 17:19-49.
43. Yokohama A., Mishra A., Mitsui T., Becknell B., Johns J., Curphey D., Blaser B.W., Vandeusen J.B., Mao H., Yu J., Caligiuri M.A. A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leuk. Res. 2010, 34:203-209.
44. Yu L., Liu C., Vandeusen J., Becknell B., Dai Z., Wu Y.Z., Raval A., Liu T.H., Ding W., Mao C., et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 2005, 37:265-274.
45. Yu J., Ershler M., Yu L., Wei M., Hackanson B., Yokohama A., Mitsui T., Liu C., Mao H., Liu S., et al. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood 2009, 113:5558-5567.
46. Zambello R., Facco M., Trentin L., Sancetta R., Tassinari C., Perin A., Milani A., Pizzolo G., Rodeghiero F., Agostini C., et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997, 89:201-211.
47. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 1998, 20:189-193.